AI accelerates brain drug repurposing for neurodegeneration
Key Questions
How is AI being applied to accelerate drug repurposing for neurodegeneration?
AI analyzes voice, iris, and stem cell assays to identify existing drugs for MND, PD, and dementia. This approach aims to shorten discovery timelines from decades to years.
What is the status of the MND-SMART trial supported by UK DRI?
MND-SMART is advancing through AI-supported repurposing efforts at the UK Dementia Research Institute. Single-cell multi-omics data further enables AI integration.
Can AI reduce the time needed to find treatments for brain diseases?
Researchers are using AI to search for treatments hiding in plain sight. The technology integrates diverse data types to speed identification of viable candidates.
AI using voice/iris/stem cell assays to speed discovery for MND/PD/dementia. UK DRI MND-SMART advancing. Single-cell multi-omics supports AI integration.
Sources (2)
Updated May 25, 2026